Conference Program Home
  My Program

All Times EDT

* = applied session       ! = JSM meeting theme

Activity Details

315 * ! Tue, 8/9/2022, 2:00 PM - 3:50 PM CC-158AB
Statistical Innovation in Biomarker-Guided Clinical Development — Invited Papers
General Methodology
Organizer(s): Sammi Tang, Servier Pharmaceuticals
Chair(s): Jian Zhu, Servier Pharmaceuticals
2:05 PM Optimize Patient Care with Machine Learning-Based Biomarkers
Jie Ding, Veracyte Inc.; Shuyang Wu, Veracyte Inc.; Jianghan Qu, Veracyte Inc.; Marla Johnson, Veracyte Inc.; Lori Lofaro, Veracyte Inc.; William Bulman, Veracyte Inc.; Sangeeta Bhorade, Veracyte Inc.; Sean Walsh, Veracyte Inc.; Jonathan Wilde, Veracyte Inc.; Giulia Kennedy, Veracyte Inc.; Jing Huang, Veracyte Inc.
2:30 PM Bayesian Adaptive Alpha Allocation for Phase III Trials with Biomarker and Overall Population Objectives
Yue Shentu, Daiichi Sankyo Inc.; Cong Chen, Merck & Co., Inc.; Xuekui Zhang, University of Victoria
2:55 PM Use of an Interactive Web Application to Support Exploratory Propensity Score Analyses: Experience from the Industry Perspective and Case Study
Elande Baro, Kite Pharma; Saran Vardhanabhuti, Kite Pharma; Jiali Yan, Kite Pharma; Qinghua Song, Kite Pharma
3:20 PM An Improved Biomarker-Guided Adaptive Patient Enrichment Design
Zhaoyang Teng, Servier Pharmaceuticals; Sammi Tang, Servier Pharmaceuticals; Jian Zhu, Servier Pharmaceuticals; Zhenwei Zhou, Boston University
3:45 PM Floor Discussion